{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Medicare", "name": "subject", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/11/opinion/soaring-drug-prices.html", "document_type": "article", "byline": [], "type_of_material": "Letter", "multimedia": [], "section_name": "Opinion", "word_count": "195", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Edith A. Rosato of the Academy of Managed Care Pharmacy writes that &#8220;the blunt instrument of government price negotiations&#8221; may be neither &#8220;necessary nor wise.&#8221;", "pub_date": "2015-05-11T00:00:00Z", "news_desk": "Letters", "headline": {"kicker": "Letter", "print_headline": "Soaring Drug Prices", "main": "Soaring Drug Prices", "content_kicker": "Letter"}, "print_page": "22", "snippet": "Edith A. Rosato of the Academy of Managed Care Pharmacy writes that &#8220;the blunt instrument of government price negotiations&#8221; may be neither &#8220;necessary nor wise.&#8221;", "_id": "5550586538f0d835cf3efad4", "slideshow_credits": null, "abstract": null}